NDC 0310-3512

CALQUENCE

Acalabrutinib

CALQUENCE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Acalabrutinib.

• Product ID: 0310-3512_b1409184-3267-4d8c-8f17-4e01f69828b1
• NDC: 0310-3512
• Product Type: Human Prescription Drug
• Proprietary Name: CALQUENCE
• Generic Name: Acalabrutinib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-08-04
• Marketing Category: NDA /
• Application Number: NDA216387
• Labeler Name: AstraZeneca Pharmaceuticals LP
• Substance Name: ACALABRUTINIB
• Active Ingredient Strength: 100 mg/1
• Pharm Classes: Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0310-3512-60

60 TABLET, FILM COATED in 1 BOTTLE (0310-3512-60)

• Marketing Start Date: 2022-08-04
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "CALQUENCE" or generic name "Acalabrutinib"

NDC	Brand Name	Generic Name
0310-0512	CALQUENCE	Acalabrutinib
0310-3512	CALQUENCE	acalabrutinib